Walter Taal

6.4k total citations · 1 hit paper
70 papers, 2.3k citations indexed

About

Walter Taal is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Walter Taal has authored 70 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 27 papers in Neurology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Walter Taal's work include Glioma Diagnosis and Treatment (37 papers), Neurofibromatosis and Schwannoma Cases (18 papers) and Meningioma and schwannoma management (17 papers). Walter Taal is often cited by papers focused on Glioma Diagnosis and Treatment (37 papers), Neurofibromatosis and Schwannoma Cases (18 papers) and Meningioma and schwannoma management (17 papers). Walter Taal collaborates with scholars based in Netherlands, Germany and United States. Walter Taal's co-authors include Martin J. van den Bent, Dieta Brandsma, Peter Sminia, Lukas J.A. Stalpers, Jacoline E. C. Bromberg, Hein G. de Bruin, Annemarie T. Swaak‐Kragten, Peter A.E. Sillevis Smitt, Jan C. Holstege and Johan M. Kros and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Walter Taal

65 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

2008 814 citations Dieta Brandsma, Walter Taal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Walter Taal Netherlands	22	1.6k	792	684	366	365	70	2.3k
Florian Stockhammer Germany	25	1.5k 0.9×	454 0.6×	475 0.7×	522 1.4×	476 1.3×	53	2.2k
Friedrich-Wilhelm Kreth Germany	26	1.4k 0.8×	782 1.0×	734 1.1×	225 0.6×	265 0.7×	56	2.0k
Marion Rapp Germany	26	2.4k 1.5×	1.1k 1.4×	996 1.5×	399 1.1×	469 1.3×	90	2.9k
Masayuki Kanamori Japan	28	1.5k 0.9×	395 0.5×	509 0.7×	677 1.8×	469 1.3×	164	2.5k
Naosuke Nonoguchi Japan	24	847 0.5×	495 0.6×	597 0.9×	374 1.0×	215 0.6×	81	1.8k
Hirohito Yano Japan	22	953 0.6×	549 0.7×	396 0.6×	241 0.7×	183 0.5×	86	1.7k
Gabriele Pöpperl Germany	24	1.2k 0.7×	1.2k 1.5×	306 0.4×	203 0.6×	277 0.8×	42	2.4k
Florence Laigle–Donadey France	30	2.1k 1.3×	478 0.6×	964 1.4×	836 2.3×	620 1.7×	74	3.1k
Anja Smits Sweden	34	1.6k 1.0×	688 0.9×	528 0.8×	1.1k 3.0×	613 1.7×	111	3.7k
Michael L. Gruber United States	20	1.5k 0.9×	935 1.2×	413 0.6×	317 0.9×	273 0.7×	44	2.4k

Countries citing papers authored by Walter Taal

Since Specialization

Citations

This map shows the geographic impact of Walter Taal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Taal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Taal more than expected).

Fields of papers citing papers by Walter Taal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Taal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Taal. The network helps show where Walter Taal may publish in the future.

Co-authorship network of co-authors of Walter Taal

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Taal. A scholar is included among the top collaborators of Walter Taal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Taal. Walter Taal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berg, Lisa, Filip De Vos, Mathilde C.M. Kouwenhoven, et al.. (2025). Chemotherapy in adult patients with pilocytic astrocytoma: a retrospective multicenter cohort study. Journal of Neuro-Oncology. 176(1). 7–7.

Rosenberg, Anna G. W., et al.. (2024). Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1. Frontiers in Endocrinology. 14. 1119159–1119159. 1 indexed citations

Wingbermühle, Ellen, et al.. (2024). Cognition and behavior in adults with neurofibromatosis type 1. Frontiers in Neurology. 15. 1476472–1476472. 1 indexed citations

French, Pim J., et al.. (2024). PL02.2.A TRAMETINIB IN NEUROFIBROMATOSIS TYPE 1 RELATED SYMPTOMATIC PLEXIFORM NEUROFIBROMAS: ONE-YEAR FOLLOW-UP OF THE TRAIN STUDY. Neuro-Oncology. 26(Supplement_5). v2–v2.

Fertitta, L., et al.. (2024). Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex. Journal of Patient-Reported Outcomes. 8(1). 52–52. 1 indexed citations

Tulen, J.H.M., et al.. (2023). Visual–spatial and visuomotor functioning in adults with neurofibromatosis type 1. Journal of Intellectual Disability Research. 67(4). 362–374. 2 indexed citations

Vos, Filip De, Rob J.A. Nabuurs, Tom J. Snijders, et al.. (2023). Practice variation in re-resection for recurrent glioblastoma: A nationwide survey among Dutch neuro-oncology specialists. Neuro-Oncology Practice. 10(4). 360–369. 3 indexed citations

Taal, Walter, Yvette van Norden, Jaap Zindler, et al.. (2023). Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma. Radiotherapy and Oncology. 184. 109674–109674. 6 indexed citations

Brandes, Alba A., Walter Taal, Michael Platten, et al.. (2022). Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101. Neuro-Oncology Practice. 9(4). 310–316. 8 indexed citations

10.

Martin, Enrico, et al.. (2022). Diagnostic value of 18F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients. Journal of Neuro-Oncology. 156(3). 559–567. 8 indexed citations

11.

Tulen, J.H.M., et al.. (2022). Plasticity of visual evoked potentials in patients with neurofibromatosis type 1. Clinical Neurophysiology. 142. 220–227. 1 indexed citations

12.

Linden, Yvette M. van der, P. D. S. Dijkstra, Alexander de Graeff, et al.. (2018). The Dutch national guideline on metastases and hematological malignancies localized within the spine; a multidisciplinary collaboration towards timely and proactive management. Cancer Treatment Reviews. 69. 29–38. 23 indexed citations

13.

Bollen, L., Wilco Jacobs, Yvette M. van der Linden, et al.. (2017). A systematic review of prognostic factors predicting survival in patients with spinal bone metastases. European Spine Journal. 27(4). 799–805. 31 indexed citations

14.

Verdijk, Robert M., et al.. (2017). Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors. PLoS ONE. 12(8). e0183155–e0183155. 13 indexed citations

15.

Taal, Walter, et al.. (2015). [New Dutch guideline on spinal metastasis: extended to include spinal localisations of haematological malignancies].. PubMed. 159. A9101–A9101. 2 indexed citations

16.

Dirven, Linda, Martin J. van den Bent, Andrew Bottomley, et al.. (2015). The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial. European Journal of Cancer. 51(10). 1321–1330. 37 indexed citations

17.

Kraan, Jaco, Peterhans van den Broek, Cornelis Verhoef, et al.. (2014). Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells. British Journal of Cancer. 111(1). 149–156. 62 indexed citations

18.

Taal, Walter, Johan M. Kros, Irene van Heuvel, et al.. (2012). Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study. Journal of Neuro-Oncology. 108(1). 195–200. 29 indexed citations

19.

Taal, Walter, Dieta Brandsma, Hein G. de Bruin, et al.. (2008). Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer. 113(2). 405–410. 328 indexed citations

20.

Taal, Walter & Jan C. Holstege. (1994). GABA and glycine frequently colocalize in terminals on cat spinal motoneurons. Neuroreport. 5(17). 2225–2228. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact